Astellas Pharma Global Development Inc.Northbrook, Illinois, United States
Disclosure information not submitted.
593 - Desirability of Outcome Ranking (DOOR) Analysis of Isavuconazole Relative to Voriconazole for the Treatment of Invasive Mold Disease (IMD)
Wednesday, October 22, 202512:30 PM - 12:35 PM US ET